Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2'-deoxy-4'-ethynyl-2-fluoroadenosine
2. Islatravir
3. Mk-8591
4. Mk8591
1. Islatravir
2. 865363-93-5
3. Mk-8591
4. Efda
5. Islatravir [usan]
6. 2'-deoxy-4'-c-ethynyl-2-fluoroadenosine
7. (2r,3s,5r)-5-(6-amino-2-fluoro-9h-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol
8. Qpq082r25d
9. Adenosine, 2'-deoxy-4'-c-ethynyl-2-fluoro-
10. Islatravir (usan)
11. E2fda
12. 2'-deoxy-4'-ethynyl-2-fluoroadenosine
13. (2r,3s,5r)-5-(6-amino-2-fluoro-purin-9-yl)-2-ethynyl-2-(hydroxymethyl)tetrahydrofuran-3-ol
14. 2f-eda
15. E2-fda
16. Islatravir [inn]
17. Islatravir Anhydrous
18. 4'ed2fa
19. Mk-8591 (islatravir)
20. Islatravir [who-dd]
21. Unii-qpq082r25d
22. Chembl517231
23. Schembl2528556
24. 4'-e-d2-fa
25. Dtxsid601046407
26. Mk8591
27. Nsc787789
28. Nsc-787789
29. (2r,3s,5r)-5-(6-amino-2-fluoropurin-9-yl)-2-ethynyl-2-(hydroxymethyl)oxolan-3-ol
30. Hy-104012
31. Cs-0023675
32. A51131
33. D11432
34. A848914
35. 2'-deoxy-4'-c-ethynyl-2-fluoroadenosine;mk-8591
36. Q24977417
37. 9h-purin-6-amine, 9-(2-deoxy-4-c-ethynyl-.beta.-d-erythro-pentofuranosyl)-2-fluoro-
| Molecular Weight | 293.25 g/mol |
|---|---|
| Molecular Formula | C12H12FN5O3 |
| XLogP3 | -0.6 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 293.09241742 g/mol |
| Monoisotopic Mass | 293.09241742 g/mol |
| Topological Polar Surface Area | 119 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 459 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Retroviral Agents
Agents used to treat RETROVIRIDAE INFECTIONS. (See all compounds classified as Anti-Retroviral Agents.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Nucleic Acid Synthesis Inhibitors
Compounds that inhibit cell production of DNA or RNA. (See all compounds classified as Nucleic Acid Synthesis Inhibitors.)
Reverse Transcriptase Inhibitors
Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. (See all compounds classified as Reverse Transcriptase Inhibitors.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Islatravir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Islatravir, including repackagers and relabelers. The FDA regulates Islatravir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Islatravir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Islatravir supplier is an individual or a company that provides Islatravir active pharmaceutical ingredient (API) or Islatravir finished formulations upon request. The Islatravir suppliers may include Islatravir API manufacturers, exporters, distributors and traders.
Islatravir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Islatravir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Islatravir GMP manufacturer or Islatravir GMP API supplier for your needs.
A Islatravir CoA (Certificate of Analysis) is a formal document that attests to Islatravir's compliance with Islatravir specifications and serves as a tool for batch-level quality control.
Islatravir CoA mostly includes findings from lab analyses of a specific batch. For each Islatravir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Islatravir may be tested according to a variety of international standards, such as European Pharmacopoeia (Islatravir EP), Islatravir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Islatravir USP).
LOOKING FOR A SUPPLIER?
